Journal of Medicinal Chemistry 1990-12-01

Hemoglobin S antigelation agents based on 5-bromotryptophan with potential for sickle cell anemia.

P Z De Croos, P Sangdee, B L Stockwell, L Kar, E B Thompson, M E Johnson, B L Currie

Index: J. Med. Chem. 33(12) , 3138-42, (1990)

Full Text: HTML

Abstract

5-Bromotryptophan (5-BrTrp) is the most potent amino acid derivative reported in the literature to inhibit the gelation of hemoglobin S (from sickle cell anemia patients). Trp-Trp is also more potent than Trp as an antigelation agent. Therefore, we have prepared a series of dipeptides containing 5-BrTrp and evaluated the antigelation activity. 5-BrTrp-5-BrTrp is the most potent, i.e., 5.9 times the activity of Trp, followed by 5-BrTrp-Trp and then Trp-5-BrTrp. This improved antigelation potency for 5-BrTrp-5-BrTrp and 5-BrTrp-Trp is very significant and will be pursued further as lead compounds with potential for sickle cell anemia.

Related Compounds

  • 5-Bromotryptophan

Related Articles:

Analysis of bromotryptophan and hydroxyproline modifications by high-resolution, high-accuracy precursor ion scanning utilizing fragment ions with mass-deficient mass tags.

2002-12-15

[Anal. Chem. 74(24) , 6230-6, (2002)]

11-fold symmetry of the trp RNA-binding attenuation protein (TRAP) from Bacillus subtilis determined by X-ray analysis.

1994-11-18

[J. Mol. Biol. 244(1) , 1-5, (1994)]

Location of potential binding sites on deoxy hemoglobin for the design of antigelling agents.

1992-02-05

[J. Mol. Biol. 223(3) , 791-800, (1992)]

Photoaffinity labelling of cyanomethaemoglobin with derivatives of tryptophan and 5-bromotryptophan.

1995-05-15

[Biochem. J. 308 ( Pt 1) , 251-60, (1995)]

More Articles...